Pfizer vs Nifty 50: Share Price Performance Compared

Pfizer vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Pfizer trades on the NSE under the symbol PFIZER, and its 1-month return of -10.09% compares with -5.12% for the Nifty 50 over the same period.

The Pfizer vs Nifty 50 comparison matters because Pfizer is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Pfizer share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 8 October 2026.

Also read – PC Jeweller vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Pfizer vs Nifty 50: Performance at a Glance

The table below sets out the Pfizer vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.

Time Frame	Pfizer Return	Nifty 50 Return	Difference
1 Month	-10.09%	-5.12%	-4.97 pp
3 Months	-18.30%	-7.22%	-11.08 pp
6 Months	-21.04%	-6.49%	-14.55 pp
1 Year	-28.80%	-11.71%	-17.09 pp
3 Years	-5.32%	+13.94%	-19.26 pp

On the Pfizer vs Nifty 50 scorecard, Pfizer has trailed the index over the latest 1-year window, returning -28.80% against -11.71% for the Nifty 50, a difference of 17.09 percentage points. The widest gap on the table is over three years, where Pfizer fell 5.32% while the Nifty 50 gained 13.94%, a difference of 19.26 percentage points against the stock. Both Pfizer and the index lost ground over the past year, so the comparison here is about which of the two lost less.

Check the Univest Screener for live Pfizer and Nifty 50 data

Latest Close and 52-Week Range: Pfizer and the Nifty 50

Instrument	Latest Close	52-Week High	52-Week Low	Vs 52-Week High
Pfizer	Rs 3,750.00	Rs 5,578.50	Rs 3,731.00	-32.8%
Nifty 50	22,231.80	26,373.20	22,179.90	-15.7%

Pfizer closed at Rs 3,750.00 on 8 October 2026, which is 32.8% below its 52-week high of Rs 5,578.50 and 0.5% above its 52-week low of Rs 3,731.00. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Pfizer vs Nifty 50 Gap Exists

Pfizer can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Pfizer has traded between Rs 3,731.00 and Rs 5,578.50, a spread of 49.5% from low to high, against 18.9% for the Nifty 50.

Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move Pfizer's price sharply in either direction, while the Nifty 50's return reflects the blended earnings of its constituents and is far less exposed to any single company's news.

Download the Univest iOS App or Univest Android App to track Pfizer and Nifty 50 live on the go.

Pfizer vs Nifty 50: Has Pfizer Beaten the Benchmark?

No, not over the past year. Pfizer returned -28.80% against -11.71% for the Nifty 50, a shortfall of 17.09 percentage points. Across all five time frames measured, Pfizer is behind the index.

Risks of the Pfizer vs Nifty 50 Comparison

Reading too much into a Pfizer vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.

Also read – Pine Labs vs Nifty 50: Returns Compared

Pfizer carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 3,731.00 to Rs 5,578.50 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Pfizer vs Nifty 50 currently reads in the index's favour on every time frame measured, with the widest shortfall over three years. That does not rule out a change in direction, but investors should factor Pfizer's volatility, liquidity and sector concentration into any decision and consult a SEBI-registered advisor first.

Has Pfizer outperformed the Nifty 50 in the last year?

Ans. No. Pfizer returned -28.80% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.

How does Pfizer vs Nifty 50 look over 3 years?

Ans. Over three years Pfizer has returned -5.32% compared with the Nifty 50's +13.94%, so in the Pfizer vs Nifty 50 comparison the stock has been behind over this horizon.

What is the Pfizer share price today compared to Nifty 50?

Ans. Pfizer share price closed at Rs 3,750.00 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.

What is the 52-week high and low of Pfizer?

Ans. Pfizer's 52-week high is Rs 5,578.50 and its 52-week low is Rs 3,731.00, based on NSE data. The latest close of Rs 3,750.00 is 32.8% below the high.

Why does Pfizer show bigger price swings than the Nifty 50?

Ans. Pfizer carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Pfizer has traded in a 49.5% low-to-high range against 18.9% for the index, a key reason the Pfizer vs Nifty 50 return gap varies across time frames.

Is Pfizer a good long-term investment compared to a Nifty 50 index fund?

Ans. Pfizer's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Pfizer vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.